Kopp Family Office »

Miragen Therapeutics shares owned by Kopp Family Office

Quarter-by-quarter ownership of Miragen Therapeutics (VRDN) shares owned by Kopp Family Office from 13F filings

Historical chart of Kopp Family Office investment in Miragen Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Miragen Therapeutics held by Kopp Family Office consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Miragen Therapeutics by Kopp Family Office

Quarter filed Position value Share count Share price at filing
2023-09-30 $3.3M 214k 15.34
2023-06-30 $5.1M 214k 23.79
2023-03-31 $3.3M 131k 25.44
2022-12-31 $1.9M 64k 29.21